Ofri Mosenzon has received research grant support through Hadassah Hebrew University Hospital, Novo Nordisk and AstraZeneca
Regulatory framework and challenges for live biotherapeutic products in Taiwan
Available from: Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al
Contact your GP or prescribing clinician if you notice: Mood changes that feel disproportionate or unusual for you Irritability or emotional instability affecting relationships or work Anxiety that develops or worsens after starting treatment Sleep disturbances, particularly insomnia or excessive sleeping Symptoms of hypoglycaemia if you have diabetes (confusion, tremor, sweating, rapid heartbeat) Your healthcare provider can assess whether symptoms relate to the medication, underlying mental health conditions, or other factors